This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fisher, A. Articles by Davies, E. Search for Related Content PubMed PubMed Citation Articles by Fisher, A. Articles by Davies, E.

Effects of 18-Hydroxylated Steroids on Corticosteroid Production by Human Aldosterone Synthase and 11ß-Hydroxylase

Medical Research Council Blood Pressure Group, Department of Medicine and Therapeutics (A.F., E.C.F., J.M.C.C., R.F., E.D.), Western Infirmary, Glasgow, Scotland G11 6NT; Department of Biochemistry, Universität des Saarlandes (R.B.), D-66041 Saarbrucken, Germany; and University of Mississippi Medical Center and the G. V. (Sonny) Montgomery Veterans Affairs Hospital (C.G.-S.), Jackson, Mississippi 39216

Address all correspondence and requests for reprints to: Prof. R. Fraser, Medical Research Council Blood Pressure Group, Department of Medicine and Therapeutics, Western Infirmary, Glasgow, Scotland G11 6NT. E-mail: rfraser{at}clinmed.gla.ac.uk

Abstract

In glucocorticoid-suppressible hyperaldosteronism, 11ß- hydroxylase activity is impaired. A chimeric enzyme formed from the control elements of 11ß-hydroxylase and the structural elements of aldosterone synthase is expressed ectopically in the zona fasciculata, thus exposing cortisol to aldosterone synthase. Increased quantities of 18-hydroxycortisol and 18-oxocortisol are synthesized, which, it has been suggested, might have a local inhibitory effect on the normal 11ß-hydroxylase. The effects of these compounds and also of 18-hydroxydeoxycorticosterone were tested in cells stably transfected with CYP11B1 and CYP11B2, the genes encoding 11ß-hydroxylase and aldosterone synthase, respectively. Neither 18-hydroxycortisol nor 18-oxocortisol affected the efficiency of use of 11-deoxycorticosterone or 11-deoxycortisol as substrates by the enzymes. 18-Hydroxydeoxycorticosterone significantly reduced the conversion rate of 11-deoxycorticosterone to corticosterone and that of 11-deoxycortisol to cortisol by both enzymes, but the production rate of 18- hydroxycorticosterone and aldosterone by aldosterone synthase increased. Aldosterone synthase was able to convert 18-hydroxydeoxycorticosterone to 18-hydroxycorticosterone and aldosterone, although its affinity for this substrate was lower (4.76 µmol/liter) than that for 11-deoxycorticosterone (0.11 µmol/liter). 11ß-Hydroxylase was unable to convert 18- hydroxydeoxycorticosterone to 18-hydroxycorticosterone. 18-Hydroxycortisol and 18-oxocortisol are not, therefore, the cause of lower 11ß-hydroxylase activity in glucocorticoid- suppressible hyperaldosteronism. 18-Hydroxydeoxycorticosterone can be converted to aldosterone, but its local concentration in man and its K_m suggest that it is unlikely to be important.

This article has been cited by other articles:

				F. J. Charchar, M. Tomaszewski, S. Padmanabhan, B. Lacka, M. N. Upton, G. C. Inglis, N. H. Anderson, A. McConnachie, E. Zukowska-Szczechowska, W. Grzeszczak, et al. The Y Chromosome Effect on Blood Pressure in Two European Populations Hypertension, February 1, 2002; 39(2): 353 - 356. [Abstract] [Full Text] [PDF]